February 1, 2013 — SoftVue, the whole breast ultrasound device created by two scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine, is currently undergoing review by the U.S. Food and Drug Administration (FDA) for market clearance.
A patient's relationship with his or her doctor has long been considered an important component of healing. Now, in a novel investigation in which physicians underwent brain scans while they believed they were actually treating patients, researchers have provided the first scientific evidence indicating that doctors truly can feel their patients' pain — and can also experience their relief following treatment.
February 1, 2013 — Six clinical trials, including one evaluating the effectiveness of proton beam therapy in treating children with specific brain cancers and three proton therapy trials for men with prostate cancer, are being led by researchers at CDH Proton Center, A ProCure Center.
In June, the Philips Radiology Experience Tour hit the road to provide healthcare professionals with an opportunity to ...
Accu-Tatt is an easy-to-use, sterile, all inclusive tattooing device designed to permanently mark radiation therapy patients. Every Accu-Tatt pouch conveniently contains an ink ampoule and a ¾-inch, 22-gauge needle. Packaging the needle and ampoule in a sterilized pouch reduces the concern for contamination and cross-contamination within radiation therapy facilities. In addition, Accu-Tatt’s short needle length allows for increased control while tattooing the patient. The Accu-Tatt shell contains an ampoule filled with sterile black ink. To start the flow of ink, hold the ampoule upright in one hand and use the thumb to bend the shell, breaking the ampoule. The end of the ampoule houses a luer lock fitting to accommodate the prepackaged, sterilized hypodermic needle.
Analogic Corp. is acquiring Ultrasonix Medical Corp., a supplier of ultrasound systems for point-of-care and general imaging applications. Ultrasonix has more than 5,000 systems installed worldwide, and would bring key ultrasound products, technology and sales channels that are complementary to Analogic's ultrasound business.
In what one day may be recognized as a melding of epidemiology and medical imaging, researchers are associating human conditions once viewed as unavoidable or natural consequences of American life as diseases with commonalities that can be seen and measured in the living brain.
This summer, the Philips Radiology Experience Tour has been bringing Philips imaging modalities directly to the ...
Matakina International announced that the Volpara objective breast density measurement software will be used in the European Union (EU) collaborative Adapting Breast Cancer Screening Strategy Using Personalised Risk Estimation (ASSURE) research project.
Fujifilm Medical Systems U.S.A. Inc. shared the benefits of its zero footprint mobile application, Synapse Mobility, with visitors to the 2012 meeting of the Radiological Society of North America (RSNA). The application enables access to Fujifilm’s suite of Synapse products from hand-held devices, in addition to Macintosh- or Windows-based PCs. It was one of several Synapse products and solutions demonstrated at the show.
Samsung Electronics America, Inc., a subsidiary of Samsung Electronics Co. Ltd, announced its acquisition of NeuroLogica, a leading computed tomography (CT) company headquartered in Danvers, Massachusetts. Established in 2004, NeuroLogica develops cutting-edge medical imaging products and is known for its world-class portable CT scanners, such as BodyTom and CereTom. Terms of the deal were not disclosed.
In a study designed to see if doctors who are told the exact price of expensive medical tests like magnetic resonance imaging (MRI) in advance would order fewer of them, Johns Hopkins researchers got their answer: No.
Varian Medical Systems has received a U.S. Food and Drug Administration (FDA)- 510(k) clearance for the latest version of its Vitesse real time planning for HDR brachytherapy which is used to plan and perform high-dose-rate (HDR), ultrasound-guided brachytherapy treatments for prostate cancer.
Avreo announced the release of Version 7.4 for preview at HIMSS 2013. Version 7.4 enhancements include voice recognition improvements such as voice command shortcuts, advanced report template management and new voice recognition editor workflow to offer interpreting physicians the option to send voice recognition reports to an editor for final review prior to distribution.
Fujifilm recently expanded its enterprise imaging portfolio with Synapse Pathology, the company’s newly acquired and ...
Sports-related concussions and mild traumatic brain injuries have grabbed headlines in recent months, as the long-term damage they can cause becomes increasingly evident among both current and former athletes. The Centers for Disease Control and Prevention estimates that millions of these injuries occur each year.
The study finds that in several countries in Western Europe there are too few radiotherapy machines to ensure that cancer patients in need of radiotherapy receive treatment. For instance, in Italy around 16 percent of need is unmet, in Portugal 19 percent, Austria 20 percent and the UK and Germany 21 percent. However, the authors caution that these apparent gaps in treatment supply may be compensated by more efficient organization of radiotherapy provision.
Elekta and Philips Healthcare announced The University of Texas MD Anderson Cancer Center (Houston, Texas) has signed an agreement to join a research group to advance the development of an innovative image-guided treatment technology for cancer care. The technology merges radiation therapy and magnetic resonance imaging (MRI) technology in a single system. MD Anderson is the second member of the research consortium, which will comprise leading radiation oncology centers and clinicians, and already includes the University Medical Center Utrecht (the Netherlands).
Cerner’s PowerChart cardiovascular solution unifies diagnostic cardiology activities, therapeutic interventions and follow-up regimens into a unified electronic health record (EHR) for the patient. This greatly simplifies workflow and enables cardiologists to see a consolidated view of clinical information from within Cerner’s EHR, PowerChart. Cerner’s partnership with Merge Cardio and Merge Hemo provides cardiac imaging for catheterization, intravascular ultrasound, echocardiography and nuclear medicine; facilitates structured reporting for cardiologist clinical interpretations; and integrates hemodynamics data with the Cerner EMR.
According to Millennium Research Group (MRG), the segment of the U.S. nonvascular interventional radiology device market with the fastest growth and greatest potential is ablation devices, comprising radiofrequency (RF) ablation, cryoablation and microwave ablation devices. The overall market will grow moderately to $295 million by 2017.
The Radiological Society of North America (RSNA) Meeting, held annually in Chicago, Ill., is one of the largest and most prestigious medical imaging conferences in the world. Top researchers often choose this venue to announce significant results from their clinical work. One of the most exciting areas of modern medicine discussed at last year's meeting was molecular imaging. Many attendees expressed interest towards a full session dedicated to this new form of imaging entitled, "Breast Imaging in the Era of Molecular Medicine."
Apollo Hospitals, India's leading healthcare provider, in its yet another initiative to bring the best healthcare practices to India, announced its plans to establish a Proton Therapy Center in India, the first of its kind across South East Asia, Africa and Australia. This launch, which marks the beginning of the next wave of advancement in radiation therapy in India, is worth approximately Rs. 400 crores, which covers the equipment and services supplied by Ion Beam Applications S.A. (IBA) to help establish the Apollo Proton Therapy Center including the long-term operation and maintenance contract.
MIM Software Inc. announced today that Stereotactic Surface Projection images (SSP) have been added to the quantitative analysis tools for amyloid PET in the new version 5.6 of MIMneuro.